Reviewer's report
Title:Factors Linked to Severe Thrombocytopenia During Antiviral Therapy in
Patients with Chronic Hepatitis C and Pretreatment Low Platelet Counts
Version: 2Date:25 August 2011
Reviewer: Edoardo Giovanni Giannini
Reviewer's report:
The Authors have revised the paper following the suggestions, and the updated
version in improved in many points. I still have some minor queries.
Minor Essential Revisions.
- Page 6, 2nd line from the bottom: "...in whom liver biopsy was performed".
- Page 7, line 11. It is unlikely that "newly developed thrombocytopenia" was
categorised "deterioration" as the absence of thrombocytopenia was an
exclusion criteria of the study.
Level of interest: An article of importance in its field
Quality of written English: Acceptable
Statistical review: Yes, and I have assessed the statistics in my report.
Declaration of competing interests:
Conflict of Interests Statement:
Edoardo G. Giannini received travel and lectures grant from
Merck/Schering-Plough, Hoffman-LaRoche, and GlaxoSmithKline.
Reviewer's report
Title:Factors Linked to Severe Thrombocytopenia During Antiviral Therapy in
Patients with Chronic Hepatitis C and Pretreatment Low Platelet Counts
Version: 2Date:25 August 2011
Reviewer: Edoardo Giovanni Giannini
Reviewer's report:
The Authors have revised the paper following the suggestions, and the updated
version in improved in many points. I still have some minor queries.
Minor Essential Revisions.
- Page 6, 2nd line from the bottom: "...in whom liver biopsy was performed".
- Page 7, line 11. It is unlikely that "newly developed thrombocytopenia" was
categorised "deterioration" as the absence of thrombocytopenia was an
exclusion criteria of the study.
Level of interest: An article of importance in its field
Quality of written English: Acceptable
Statistical review: Yes, and I have assessed the statistics in my report.
Declaration of competing interests:
Conflict of Interests Statement:
Edoardo G. Giannini received travel and lectures grant from
Merck/Schering-Plough, Hoffman-LaRoche, and GlaxoSmithKline.
Please review this paper.
user
Reviewer's report
Title:Factors Linked to Severe Thrombocytopenia During Antiviral Therapy in
Patients with Chronic Hepatitis C and Pretreatment Low Platelet Counts
Version: 2Date:25 August 2011
Reviewer: Edoardo Giovanni Giannini
Reviewer's report:
The Authors have revised the paper following the suggestions, and the updated
version in improved in many points. I still have some minor queries.
Minor Essential Revisions.
- Page 6, 2nd line from the bottom: "...in whom liver biopsy was performed".
- Page 7, line 11. It is unlikely that "newly developed thrombocytopenia" was
categorised "deterioration" as the absence of thrombocytopenia was an
exclusion criteria of the study.
Level of interest: An article of importance in its field
Quality of written English: Acceptable
Statistical review: Yes, and I have assessed the statistics in my report.
Declaration of competing interests:
Conflict of Interests Statement:
Edoardo G. Giannini received travel and lectures grant from
Merck/Schering-Plough, Hoffman-LaRoche, and GlaxoSmithKline.
assistant